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Cerium oxide nanoparticles NanoCeO2 and chitosan CH based nanobiocomposite film deposited
onto indium-tin-oxide coated glass substrate has been used to coimmobilize rabbit immunoglobin
r-IgGs and bovine serum albumin BSA for food borne mycotoxin ochratoxin-A OTA
detection. Electrochemical studies reveal that presence of NanoCeO2 increases effective
electro-active surface area of CH-NanoCeO2/indium tin oxide ITO nanobiocomposite resulting in
high loading of r-IgGs. BSA / r-IgGs /CH-NanoCeO2 / ITO immunoelectrode exhibits improved
linearity 0.25–6.0 ng/dl, detection limit 0.25 ng/dl, response time 25 s, sensitivity
18 A /ng dl−1 cm−2, and regression coefficient r20.997. © 2009 American Institute of
Physics. doi:10.1063/1.3249586
Electrochemical immunosensors due to accuracy,
sensitivity, selectivity and cost-effectiveness have been ex-
tensively used to detect proteins, biomarkers, biological
toxins, and biological-warfare agents in critical situations,
food, environment, pharmaceutical chemistry, and clinical
diagnostics.1–3 The choices of nanomaterials as appropriate
matrices due to unique optical, electrical, and molecular
properties and in particular high reactivity and beneficial
chemically tailored physicochemical properties have been
utilized for antibodies immobilization with proper orienta-
tion that help to obtain sensitive, compact, and stable
immunosensor.2,3
Among nanomaterials, metal oxides have been found to
exhibit high surface-to-volume ratio, high surface reaction
activity, high catalytic efficiency, and strong adsorption abil-
ity that make them potential candidate materials for the fab-
rication of biosensor.2–5 Among these, nanostructured CeO2
due to high mechanical strength, oxygen ion conductivity,
biocompatibility, oxygen storage capacity, nontoxicity, high
chemical stability and high electron transfer have aroused
much interest for development of implantable biosensors.
Moreover, high isoelectric point IEP of CeO2 9.2 can
be helpful to immobilize desired biomolecules of low IEP via
electrostatic interactions.2,5–13
Nanostructured CeO2 has been used for various biosen-
sor applications such as immunosensor for mycotoxin,2 to
immobilize cholesterol oxidase/glucose oxidase to detect
cholesterol/glucose,5–7 as an insoluble oxidant to minimize
interferents,8 for hydrogen peroxide detection via immobiliz-
ing horseradish peroxidase,9,10 and DNA hybridization
detection.11 However, there is a considerable scope to im-
prove the biosensing characteristics of NanoCeO2 by dis-
persing these in electroactive biopolymer e.g., chitosan CH
to fabricate nanobiocomposite. CH due to its excellent film-
forming ability, mechanical strength, biocompatibility, non-
toxicity, susceptibility to chemical modification, cost-
effectiveness, etc., has been explored for biosensor
development.3 Moreover, amino groups of CH provide a hy-
drophilic environment compatible with the biomolecules.3,14
In this context, nanoporous CH-NanoCeO2 composite has
been used to fabricate DNA and cholesterol biosensor.12,13
We report results of studies relating to coimmobilization
of r-IgG and BSA onto CH-NanoCeO2 nanobiocomposite
film onto indium-tin-oxide coated glass substrate for OTA
detection. BSA / r-IgGs /CH-NanoCeO2/indium tin oxide
ITO immunosensor shows improved sensing characteris-
tics. OTA is produced by several species of Aspergillus and
Penicillium and occurs in a variety of food commodities that
causes nephrotoxin, hepatotoxin, teratogen, and carcinogen
group 2B, possibly by induction of oxidative DNA
damage.2,3
All chemicals of analytical grade were purchased from
Sigma Aldrich. 1 gm of cerium ammonium nitrate was dis-
solved in distilled 20 ml de-ionized water. NanoCeO2
10 mg, synthesized using co-precipitation13 method is dis-
persed in 10 ml of CH solution prepared by dissolving
50 mg CH in 10 ml of acetate buffer 0.05M, pH 4.2 solu-
tion by constant stirring at room temperature 25 °C. The
nanocomposite films are fabricated by uniformly spreading
10 l solution of CH-NanoCeO2 nanobiocomposite onto an
ITO 0.25 cm2 surface and dried at room temperature for
about 12 h and then washed with deionized water to remove
any unbound particles. OTA Aspergillus ochraceus solution
is prepared in phosphate buffer PB, 50 mM, pH 7.0 with
10% methanol. Solution of r-IgGs is prepared in PB. The
immobilization of r-IgG has been carried out by spreading
10 l solution onto the CH-NanoCeO2 nanobiocomposite
electrode. BSA 98% dissolved in PB is used as the block-
ing agent for nonspecific binding sites. Both the solutions
containing 0.015M NaN3 as a preservative are aliquoated
and stored at −20 °C.
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X-ray diffraction studies XRD Rigaku, miniflux 2
have been used to confirm formation of CeO2 nanoparticles.
Scanning electron microscope SEM LEO-440, Fourier
transform infrared FTIR Perkin Elmer and Autolab
Potentiostat/Galvanostat are used to characterize electrodes
and immunoelectrodes. The electrochemical studies differ-
ential pulse voltammetry DPV and cyclic voltammetry
CV are carried out in phosphate buffer saline 50 mM and
0.9% NaCl containing 5 mM FeCN63−/4− at pH 7, at this
pH biomolecule retains its natural structure and activity.
XRD pattern Fig. 1a of the CeO2, synthesized using
coprecipitation method exhibits characteristic diffraction
planes corresponding to CeO2 fluorite structure.2,15 However,
the observed reflection planes are broad due to small particle
size 10 nm estimated using Scherrer’s formula. The in-
corporation of NanoCeO2 in CH matrix has been confirmed
using SEM wherein, regular planner morphology of CH
Ref. 3 changes into globular nanoporous morphology in-
set, Fig. 1a due to uniform distribution of NanoCeO2 in
CH matrix via electrostatic interaction.
FTIR spectra of CH-NanoCeO2 nanobiocomposite
Fig. 1b, curve ii shows characteristic bands corresponding
to CH curve i and the NanoCeO2 revealing the formation of
nanocomposite. The band at 465 cm−1 assigned to Ce–O
stretching in CeO2 nanoparticles13 shifts to 505 cm−1 curve
b in CH-NanoCeO2 nanobiocomposite due to electrostatic
interactions between CH and NanoCeO2. The bands at 1643
and 1560 cm−1 observed in FTIR spectra of
r-IgGs /CH-NanoCeO2 / ITO immunoelectrode circle, curve
iii correspond to amide II band of r-IgGs -sheet, main
secondary structure element of IgGs, indicating immobiliza-
tion of r-IgGs. However, presence of sharp band at
1647 cm−1 in BSA / r-IgGs /CH-NanoCeO2 / ITO immuno-
electrode circle, curve iv corresponds to amide II band of
BSA indicating immobilization of BSA.2,3 It is known that,
-0.2 -0.1 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8
0.0
5.0x10-5
1.0x10-4
1.5x10-4
2.0x10-4
2.5x10-4
3.0x10-4
3.5x10-4
4.0x10-4
4.5x10-4
5.0x10-4
-0.3 -0.2 -0.1 0.0 0.1 0.2 0.3 0.4 0.5 0.6
-4.0x10-4
-3.0x10-4
-2.0x10-4
-1.0x10-4
0.0
1.0x10-4
2.0x10-4
3.0x10-4
4.0x10-4
iv
iii
ii
i
Cu
rr
en
t(
A)
Potential (V)
a i = CH/ITO electrodeii = CH-CeO2/ITO electrode
iii = r-IgGs/CH-CeO2/ITO immunoelectrode
iv = BSA/r-IgGs/CH-CeO2/ITO immunoelectrode
iv
iii
ii
i
C
ur
re
nt
(A
)
Potential (V)
-0.6 -0.4 -0.2 0.0 0.2 0.4 0.6 0.8
-6.00x10-4
-4.50x10-4
-3.00x10-4
-1.50x10-4
0.00
1.50x10-4
3.00x10-4
4.50x10-4
6.00x10-4
7.50x10-4
3 4 5 6 7 8 9 10
-8.0x10-4
-6.0x10-4
-4.0x10-4
-2.0x10-4
0.0
2.0x10-4
4.0x10-4
6.0x10-4
8.0x10-4
Cu
rre
nt
(A
)
Scan rate (mV/s)1/2
0 10 20 30 40 50 60 70 80 90 100
0.16
0.18
0.20
0.22
0.24
0.26
0.28
0.30
0.32
Po
te
nt
ia
ld
iff
er
en
ce
(
∆∆
E=
E p
-E
C)
Scan Rate (mV/s)
b
r2 = 0.9925
r2 = 0.999
y = -1.2 x 10-4 - 5.657 x 10-5 X
y = 3.7 x 10-5 + 6.93 x 10-5 X
y = 0.164 + 0.00144 X, r2 = 0.995
C
ur
re
nt
(A
)
Potential (V)
FIG. 2. Color online a DPV studies of CH/ITO electrode curve i,
CH-NanoCeO2 / ITO electrode curve ii, r-IgGs /CH-NanoCeO2 / ITO im-
munoelectrode curve iii, and BSA / r-IgGs /CH-Nano-CeO2 / ITO immuno-
electrode curve iv. Inset: CV studies of the stepwise formation of
BSA / r-IgGs /CH-NanoCeO2 / ITO immunoelectrode. b CV studies of
BSA / r-IgGs /CH-NanoCeO2 / ITO immunoelectrode as a function of scan
rate 10–100 mV/s.
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FIG. 3. Electrochemical response of BSA / r-IgGs /CH-NanoCeO2 / ITO im-
munoelectrode as function of OTA concentration, inset: calibration curve
between electrochemical response current and OTA concentration.
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FIG. 1. Color online a XRD pattern of NanoCeO2. Inset: SEM image
of CH-NanoCeO2 / ITO nanobiocomposite. b FTIR spectra of both
CH/ITO electrode curve i, CH-NanoCeO2 / ITO electrode curve ii,
r-IgGs /CHNanoCeO2 / ITO immunoelectrode curve iii, and
BSA / rIgGs /CH-Nano-CeO2 / ITO immunoelectrode curve iv.
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in the CH-NanoCeO2 nanobiocomposite, CH with positively
NH3
+ group and surface charged NanoCeO2 IEP9.2 bind
with carboxyl terminated group fragment crystalizable Fc
of r-IgGs via electrostatic interactions and the free amino
terminated site fragment antigen binding Fab part is free
to bind with carboxylic group of OTA.
In the DPV studies Fig. 2a, the magnitude of current
response for CH-NanoCeO2 / ITO nanobiocomposite elec-
trode curve ii is higher than that of CH/ITO electrode
curve i revealing that presence of NanoCeO2 results in in-
creased electro-active surface area leading to increased ad-
sorption of redox species Fe III/IV. The presence of
NanoCeO2 in nanobiocomposite results in improved elec-
tronic and ionic transport due to uniformly distributed
NanoCeO2 within CH matrix rather than clustered matrix
SEM analysis resulting in three-dimensional electron con-
ductive network extended throughout the ion-conductive ma-
trix of CH. The surface concentration of redox species onto
CH-NanoCeO2 / ITO electrode 2.210−6 mol cm−3 is
higher than that of CH/ITO 1.410−6 mol cm−3 suggest-
ing that incorporation of NanoCeO2 increases electroactive
surface area for diffusion of electrons resulting in high elec-
trocatalytic properties of nanobiocomposite that may be re-
sponsible for improved sensing characteristics due to high
loading of r-IgGs.
The magnitude of current for r-IgGs /
CH-NanoCeO2 / ITO nanobiocomposite electrode curve iii
further increases due to available free NH3
+ group on
r-IgGs resulting in increased adsorption of redox
species. The magnitude of current decreases for
BSA / r-IgGs /CH-NanoCeO2 / ITO immunoelectrode curve
iv revealing that blocking of non-binding sites of r-IgGs and
pores of CH-NanoCeO2 / ITO electrode due to immobiliza-
tion of BSA hinder electron transfer between the medium.
The values of diffusion coefficient D for CH/ITO electrode,
CH-NanoCeO2 / ITO electrode, r-IgGs /CH-NanoCeO2 / ITO
immunoelectrode and BSA / r-IgGs /CH-NanoCeO2 / ITO im-
munoelectrode have been calculated as 2.210−7, 4.6
10−7, 7.810−7, and 6.010−7 cm2 s−1 respectively, us-
ing Randles–Sevcik equation.
The results of CV studies conducted on both
electrodes and immunoelectrode indicate similar behavior
inset, Fig. 2a. Moreover, CV studies of BSA /
r-IgGs /CH-NanoCeO2 / ITO immunoelectrode Fig. 2b as
a function of scan rate 10–100 mV/s show that magnitude
of current response exhibits linear relationship with square
root of scan rate inset, Fig. 2b, revealing a diffusion-
controlled process. The observed linear dependance of poten-
tial difference as a function of scan rate reveals the facile
electron transfer16 and follows Eqs. 1–3, respectively,
IpBSA/r-IgGs/CH-NanoCeO2/ITOA = 3.7 10−5 A + 6.93
 10−5 A s/mVscan ratemV/s1/2 with R2 = 0.984, 1
IcBSA/r-IgGs/CHNanoCeO2/ITOA = − 1.2 10−4 A − 5.66
 10−5 A s/mVscan ratemV/s1/2 with R2 = 0.978, 2
EpBSA/r-IgGs/CH-NanoCeO2/ITOV = 0.164 V
+ 0.00144 E s/mscan ratemV/s with R2 = 0.99. 3
It is observed that magnitude of the electrochemical re-
sponse current of BSA / r-IgGs /CH-NanoCeO2 / ITO immu-
noelectrode increases on addition of OTA Fig. 3 due to
formation of antigen-antibody complex between OTA and
r-IgGs on nanobiocomposite surface that acts as electron
transfer-accelerating layer. A linear relationship inset, Fig.
3 between magnitude of current and OTA concentration has
been observed and follows Eq. 4.
IA = 2.21 10−4 A + 17.5 A dL ng−1
 OTA concentration ng dl−1, R2 = 0.997. 4
The high value of the association constant Ka,4
1012 l mol−1 reveals high affinity of r-IgGs toward
OTA due to favorable conformation of r-IgGs onto
nanoporous CH-NanaoCeO2 nanobiocomposite. The
CH-NanoCeO2 / ITO based immunosensor exhibits improved
sensing characteristics such as low detection limit of
0.25 ng dl−1, high sensitivity of 17.5 A /ng dl−1 cm2,
reproducibility of 20 times and long term stability 80 days
in comparison to BSA/r-IgGs/CH/ITO and BSA / r-IgGs /
NanoCeO2 / ITO based immunosensor, that are summarized
in the supplementary table.17
In summary, NanoCeO2 increases electroactive surface
area of CH-NanoCeO2 nanobiocomposite for the immobili-
zation of r-IgGs resulting in enhanced electron transport. The
BSA / r-IgGs /CH-NanoCeO2 / ITO immunosensor represents
a new immunosensor platform for the detection of OTA and
exhibits improved sensing characteristics than that of the sol-
gel derived NanoCeO2 and CH based immunoelectrode and
may find potential application for detection of other clini-
cally important antigens such as aflatoxin, citrinin, etc.
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